ERBB2 and cancer: The PPI network for compound 1 is visualized in Figure 12A. Importantly, TP53, ATM, PTEN, CTNNB1, BRCA1, KRAS, AKT1, CDKN2A, BRCA2 and ERBB2 were identified as core compound 1 targets in cancer.